SIM
ANIK icon

Spark Investment Management’s Anika Therapeutics ANIK Stock Holding History

Spark Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21,800
Closed -$697K – 662
2018
Q2 		$697K Buy
21,800
+5,600
+35% +$231K 0.04% 405
2018
Q1 		$805K Sell
16,200
-8,400
-34% -$475K 0.05% 355
2017
Q4 		$1.33M Hold
24,600
– – 0.07% 334
2017
Q3 		$1.43M Sell
24,600
-10,900
-31% -$570K 0.08% 329
2017
Q2 		$1.75M Hold
35,500
– – 0.11% 274
2017
Q1 		$1.54M Buy
+35,500
New +$1.69M 0.1% 313

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Spark Investment Management's ANIK Position: Q3 2018 in Review

Spark Investment Management sold out of Anika Therapeutics (ANIK) in Q3 2018, closing a stake of 21,800 shares — an estimated $697K sold.

Spark Investment Management first reported a position in ANIK in Q1 2017 and held it in 6 quarters. The position peaked at $1.75M in Q2 2017. 161 funds tracked by Wall St. Rank hold ANIK as of Q3 2018.

  • Spark Investment Management reported no remaining Anika Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Spark Investment Management sold 21,800 Anika Therapeutics shares in Q3 2018, an estimated $697K.
  • Spark Investment Management first reported a position in Anika Therapeutics in Q1 2017 and held it in 6 quarters.
  • Spark Investment Management's Anika Therapeutics position peaked at $1.75M in Q2 2017.
  • 161 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2018.

Based on Spark Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.